Kiniksa Pharmaceuticals KNSA reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Kiniksa Pharmaceuticals posted an EPS of $3.18.
Revenue was up $87.04 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.15 which was followed by a 9.46% increase in the share price the next day.
Here's a look at Kiniksa Pharmaceuticals's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.41 | -0.42 | -0.65 |
| EPS Actual | -0.29 | -0.36 | -0.53 | -0.44 |
| Revenue Estimate | 28.55M | 22.77M | 20.72M | 10.18M |
| Revenue Actual | 26.97M | 32.19M | 18.75M | 12.10M |
To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
